George Lawrence Mikan III Sells 12,440 Shares of NeueHealth, Inc. (NYSE:NEUE) Stock

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III sold 12,440 shares of the business’s stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $6.13, for a total value of $76,257.20. Following the completion of the sale, the chief executive officer now owns 249,454 shares of the company’s stock, valued at $1,529,153.02. The trade was a 4.75 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

George Lawrence Mikan III also recently made the following trade(s):

• On Wednesday, March 12th, George Lawrence Mikan III sold 13,180 shares of NeueHealth stock. The shares were sold at an average price of $6.93, for a total value of $91,337.40.
• On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The stock was sold at an average price of $7.06, for a total value of $11,324.24.
• On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $191,685.40.
• On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total transaction of $233,079.34.
• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Price Performance

NYSE NEUE traded down $0.38 during midday trading on Monday, hitting $4.71. 81,052 shares of the company traded hands, compared to its average volume of 18,693. NeueHealth, Inc. has a 52 week low of $3.79 and a 52 week high of $7.66. The company’s 50-day simple moving average is $7.21 and its 200-day simple moving average is $6.01. The company has a market cap of $38.98 million, a PE ratio of -0.09 and a beta of 0.56.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada lowered their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Monday, December 9th.

Institutional Investors Weigh In On NeueHealth

A number of institutional investors have recently added to or reduced their stakes in the stock. Northern Trust Corp raised its holdings in NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after purchasing an additional 13,074 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of NeueHealth in the 4th quarter valued at about $76,000. Finally, Partners Group Holding AG purchased a new position in shares of NeueHealth in the 3rd quarter worth approximately $463,000. Institutional investors own 63.88% of the company’s stock.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.